High-dose chemotherapy with autologous haemopoietic support for advanced ovarian cancer in first com...
High-dose chemotherapy with autologous haemopoietic support for advanced ovarian cancer in first complete remission : retrospective analysis from the Solid Tumour Registry of the European Group for Blood and Marrow Transplantation (EBMT)
About this item
Full title
Author / Creator
Publisher
Basingstoke: Nature Publishing Group
Journal title
Language
English
Formats
Publication information
Publisher
Basingstoke: Nature Publishing Group
Subjects
More information
Scope and Contents
Contents
The majority of advanced ovarian cancer patients achieve an objective response following chemotherapy; however, only 20-30% are in remission after 5 years. Intraperitoneal or high-dose chemotherapy (HDC) may prolong disease-free and overall survival (OS) in patients with platinum-sensitive, small volume disease. To better define the subsets of pati...
Alternative Titles
Full title
High-dose chemotherapy with autologous haemopoietic support for advanced ovarian cancer in first complete remission : retrospective analysis from the Solid Tumour Registry of the European Group for Blood and Marrow Transplantation (EBMT)
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_67945880
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_67945880
Other Identifiers
ISSN
0268-3369
E-ISSN
1476-5365
DOI
10.1038/sj.bmt.1705007
